Key result
Novel implantable left atrial sensor enables pressure monitoring and therapy adaptation in HF patients.
Why the study?
Monitoring pressure and adapting therapy to changes in left ventricular loading conditions is essential in acute heart failure treatment and has been applied in chronic settings with pulmonary pressure monitoring systems.
Discusses the rationale for a novel implantable left atrial sensor for pressure monitoring in heart failure.
Hypothesis-generating for left atrial pressure monitoring in HF; prospective randomized trials needed before any clinical consideration.
Monitoring pressure and adapting therapy to the rapid changes of left ventricular loading conditions is the cornerstone of treatment of acute heart failure in hospitalised patients. This approach has also been translated into the chronic setting, as proved by the results of the only presently commercially available pulmonary pressure monitoring system
No takes yet. Share an insight, caveat, or question.
Mario et al. (2020) studied this question. A novel implantable left atrial sensor enables pressure monitoring and therapy adaptation for heart failure patients, expanding upon currently available pulmonary pressure monitoring systems.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: